Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial

Freeman D. et al, (2022), Schizophrenia Research, 250, 50 - 59

Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial.

Altunkaya J. et al, (2022), Journal of medical Internet research, 24

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

Dorward J. et al, (2022), British Journal of General Practice, 72, E446 - E455

Quality of life, healthcare use and costs in at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: Within-trial descriptive economic analyses of the ARCHIE randomised controlled trial

Rombach I. et al, (2022), BMJ Open, 12

Automated virtual reality (VR) therapy (gameChange) treating agoraphobic avoidance and distress in patients with psychosis: a multicentre, parallel group, single-blind, randomised controlled trial in England with mediation and moderation analyses

FREEMAN D. and FREEMAN D., (2022), Lancet Psychiatry

The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): A double-blind randomised placebo-controlled trial

Wang K. et al, (2021), European Respiratory Journal, 58

Platform Randomised trial of INterventions against COVID-19 in older peoPLE (PRINCIPLE): Protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk

Hayward G. et al, (2021), BMJ Open, 11

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

PRINCIPLE Trial Collaborative Group None. et al, (2021)

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

PRINCIPLE Collaborative Group None. et al, (2021)

Examining the effectiveness of general practitioner and nurse promotion of electronic cigarettes versus standard care for smoking reduction and abstinence in hardcore smokers with smoking-related chronic disease: Protocol for a randomised controlled trial

Begh R. et al, (2019), Trials, 20

Paper diary capture vs. electronic data capture for patient reported outcomes in Primary Care: an investigation into completion rates

Grabey J. et al, (2019), TRIALS, 20